Printer Friendly

CYTOPROBE CORPORATION ANNOUNCES REVERSE STOCK SPLIT

 SAN DIEGO, Jan. 17 /PRNewswire/ -- CytoProbe Corporation (NASDAQ: CYTP) (the "Company") today announced that it has declared a reverse stock split by which every six outstanding shares of the Company's common stock, $.15 par value, will be exchanged for one new share of the Company's common stock, $.15 par value. The Company will not issue any fractional shares but will issue one full share for any fractional shares otherwise resulting from this action. The record date and effective date of this reverse stock split is Jan. 17, 1994.
 For a period of 30 days NASDAQ will add the letter "D" at the end of CytoProbe's symbol (CYTPD).
 CytoProbe Corporation operates two primary businesses: the development, manufacturing and marketing of specialty medical devices and the development and production of oil and gas reserves.
 -0- 1/17/94
 /CONTACT: CytoProbe Corporation, 619-689-9400/
 (CYTP)


CO: CytoProbe Corporation ST: California IN: MTC OIL SU:

TW-MP -- NY068 -- 1370 01/17/94 13:44 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 17, 1994
Words:159
Previous Article:KEMPER NATIONAL INSURANCE COMPANIES DETERMINING HOW MANY POLICYHOLDERS AFFECTED BY CALIFORNIA EARTHQUAKE; ADVISES POLICYHOLDERS ON PRECAUTIONARY...
Next Article:ALLIED CLINICAL LABORATORIES ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 1993 RESULTS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters